2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary

Journal of Thoracic and Cardiovascular Surgery

Volumn 153, Issue 6, 2017, Pages 1241-1258.e29

  Pettersson, Gösta B ^a   Coselli, Joseph S ^b,c   Hussain, Syed T ^a   Griffin, Brian ^a   Blackstone, Eugene H ^a   Gordon, Steven M ^a   LeMaire, Scott A ^b,c   Woc Colburn, Laila E ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

AATS guidelines; cardiac surgery; infection; infective endocarditis; native valve endocarditis; prosthetic valve endocarditis; valve disease

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT;

ALLOGRAFT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; AORTIC VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; BLOOD VESSEL GRAFT; BRAIN HEMORRHAGE; CARDIAC SURGEON; CARDIOEMBOLIC STROKE; CONSENSUS DEVELOPMENT; DEBRIDEMENT; FOLLOW UP; HEART SURGERY; HEART VALVE REPLACEMENT; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; MITRAL VALVE PROSTHESIS; MYCOTIC ANEURYSM; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NONHUMAN; PATIENT CARE; PATIENT SAFETY; PEROPERATIVE CARE; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHETIC VALVE ENDOCARDITIS; RECURRENCE RISK; RECURRENT INFECTION; RENAL REPLACEMENT THERAPY; SCREENING; SPECIMEN HANDLING; SURGICAL APPROACH; SURGICAL RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; VALVULOPLASTY;

EID: 85016457614     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2016.09.093     Document Type: Article

References (288)

1. Svensson, L.G., Gillinov, A.M., Weisel, R.D., Keshavjee, S., Bacha, E.A., Moon, M.R., et al. The American Association for Thoracic Surgery Consensus Guidelines: reasons and purpose. J Thorac Cardiovasc Surg 151 (2016), 935–939.e1.
2. Institute of Medicine. Clinical Practice Guidelines We Can Trust, 2011, National Academies Press, Washington, DC.
3. Baddour, L.M., Wilson, W.R., Bayer, A.S., Fowler, V.G. Jr., Tleyjeh, I.M., Rybak, M.J., et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132 (2015), 1435–1486.
4. Habib, G., Lancellotti, P., Antunes, M.J., Bongiorni, M.G., Casalta, J.P., Del Zotti, F., et al. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36 (2015), 3075–3128.
5. Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P. III, Guyton, R.A., et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 (2014), 2440–2492.
6. Byrne, J.G., Rezai, K., Sanchez, J.A., Bernstein, R.A., Okum, E., Leacche, M., et al. Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg 91 (2011), 2012–2019.
7. Gould, F.K., Denning, D.W., Elliott, T.S., Foweraker, J., Perry, J.D., Prendergast, B.D., et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 67 (2012), 269–289.
8. Svensson, L.G., Adams, D.H., Bonow, R.O., Kouchoukos, N.T., Miller, D.C., O'Gara, P.T., et al. Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg 95 (2013), S1–S66.
9. Chirouze, C., Alla, F., Fowler, V.G. Jr., Sexton, D.J., Corey, G.R., Chu, V.H., et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin Infect Dis 60 (2015), 741–749.
10. Galvez-Acebal, J., Almendro-Delia, M., Ruiz, J., de Alarcon, A., Martinez-Marcos, F.J., Reguera, J.M., et al. Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study. Mayo Clin Proc 89 (2014), 1397–1405.
11. Lalani, T., Chu, V.H., Park, L.P., Cecchi, E., Corey, G.R., Durante-Mangoni, E., et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 173 (2013), 1495–1504.
12. Sy, R.W., Kritharides, L., Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 31 (2010), 1890–1897.
13. Curlier, E., Hoen, B., Alla, F., Selton-Suty, C., Schubel, L., Doco-Lecompte, T., et al. Relationships between sex, early valve surgery and mortality in patients with left-sided infective endocarditis analysed in a population-based cohort study. Heart 100 (2014), 1173–1178.
14. Tleyjeh, I.M., Kashour, T., Zimmerman, V., Steckelberg, J.M., Wilson, W.R., Baddour, L.M., The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J 156 (2008), 901–909.
15. Tleyjeh, I.M., Ghomrawi, H.M., Steckelberg, J.M., Hoskin, T.L., Mirzoyev, Z., Anavekar, N.S., et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 115 (2007), 1721–1728.
16. Aksoy, O., Sexton, D.J., Wang, A., Pappas, P.A., Kourany, W., Chu, V., et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 44 (2007), 364–372.
17. Vikram, H.R., Buenconsejo, J., Hasbun, R., Quagliarello, V.J., Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 290 (2003), 3207–3214.
18. Karchmer, A.W., Bayer, A.S., Editorial commentary: surgical therapy for Staphylococcus aureus prosthetic valve endocarditis: proceed with caution (Caveat Emptor). Clin Infect Dis 60 (2015), 750–752.
19. Fernandez-Hidalgo, N., Almirante, B., Tornos, P., Gonzalez-Alujas, M.T., Planes, A.M., Larrosa, M.N., et al. Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital—prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 17 (2011), 769–775.
20. Lalani, T., Cabell, C.H., Benjamin, D.K., Lasca, O., Naber, C., Fowler, V.G. Jr., et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 121 (2010), 1005–1013.
21. Sy, R.W., Bannon, P.G., Bayfield, M.S., Brown, C., Kritharides, L., Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes 2 (2009), 469–474.
22. Kanafani, Z.A., Kanj, S.S., Cabell, C.H., Cecchi, E., de Oliveira Ramos, A., Lejko-Zupanc, T., et al. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. Eur J Clin Microbiol Infect Dis 29 (2010), 1203–1210.
23. Steckelberg, J.M., Melton, L.J. III, Ilstrup, D.M., Rouse, M.S., Wilson, W.R., Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 88 (1990), 582–588.
24. Tleyjeh, I.M., Ghomrawi, H.M., Steckelberg, J.M., Montori, V.M., Hoskin, T.L., Enders, F., et al. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol 63 (2010), 130–135.
25. Kouchoukos, N.T., Blackstone, E.H., Hanley, F.L., Kirklin, J., Cardiac Surgery. 4th ed., 2012, Elsevier, Philadelphia.
26. Austin, P.C., Platt, R.W., Survivor treatment bias, treatment selection bias, and propensity scores in observational research. J Clin Epidemiol 63 (2010), 136–138.
27. Blackstone, E.H., Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002), 8–15.
28. Robins, J.M., Hernan, M.A., Brumback, B., Marginal structural models and causal inference in epidemiology. Epidemiology 11 (2000), 550–560.
29. Conn, H.O., Snyder, N., Atterbury, C.E., The Berkson bias in action. Yale J Biol Med 52 (1979), 141–147.
30. Osler, W., The Gulstonian lectures, on malignant endocarditis. Br Med J 1 (1885), 467–470.
31. Murdoch, D.R., Corey, G.R., Hoen, B., Miro, J.M., Fowler, V.G. Jr., Bayer, A.S., et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169 (2009), 463–473.
32. Hoen, B., Duval, X., Clinical practice. Infective endocarditis. N Engl J Med 368 (2013), 1425–1433.
33. Bashore, T.M., Cabell, C., Fowler, V. Jr., Update on infective endocarditis. Curr Probl Cardiol 31 (2006), 274–352.
34. Gaca, J.G., Sheng, S., Daneshmand, M.A., O'Brien, S., Rankin, J.S., Brennan, J.M., et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg 141 (2011), 98–106 e1-2.
35. Bouza, E., Menasalvas, A., Munoz, P., Vasallo, F.J., del Mar Moreno, M., Garcia Fernandez, M.A., Infective endocarditis—a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 80 (2001), 298–307.
36. Hoen, B., Alla, F., Selton-Suty, C., Beguinot, I., Bouvet, A., Briancon, S., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288 (2002), 75–81.
37. Moreillon, P., Que, Y.A., Infective endocarditis. Lancet 363 (2004), 139–149.
38. Cabell, C.H., Jollis, J.G., Peterson, G.E., Corey, G.R., Anderson, D.J., Sexton, D.J., et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162 (2002), 90–94.
39. Tleyjeh, I.M., Steckelberg, J.M., Murad, H.S., Anavekar, N.S., Ghomrawi, H.M., Mirzoyev, Z., et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293 (2005), 3022–3028.
40. Hill, E.E., Herijgers, P., Claus, P., Vanderschueren, S., Herregods, M.C., Peetermans, W.E., Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28 (2007), 196–203.
41. Mylonakis, E., Calderwood, S.B., Infective endocarditis in adults. N Engl J Med 345 (2001), 1318–1330.
42. Cabell, C.H., Abrutyn, E., Fowler, V.G. Jr., Hoen, B., Miro, J.M., Corey, G.R., et al. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 150 (2005), 1092–1098.
43. Hussain, S.T., Shrestha, N.K., Gordon, S.M., Houghtaling, P.L., Blackstone, E.H., Pettersson, G.B., Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis. J Thorac Cardiovasc Surg 148 (2014), 981–988.e4.
44. David, T.E., Gavra, G., Feindel, C.M., Regesta, T., Armstrong, S., Maganti, M.D., Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 133 (2007), 144–149.
45. Manne, M.B., Shrestha, N.K., Lytle, B.W., Nowicki, E.R., Blackstone, E., Gordon, S.M., et al. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis. Ann Thorac Surg 93 (2012), 489–493.
46. Thuny, F., Grisoli, D., Collart, F., Habib, G., Raoult, D., Management of infective endocarditis: challenges and perspectives. Lancet 379 (2012), 965–975.
47. Kang, D.H., Kim, Y.J., Kim, S.H., Sun, B.J., Kim, D.H., Yun, S.C., et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366 (2012), 2466–2473.
48. Gordon, S.M., Pettersson, G.B., Native-valve infective endocarditis—when does it require surgery?. N Engl J Med 366 (2012), 2519–2521.
49. Tleyjeh, I.M., Abdel-Latif, A., Rahbi, H., Scott, C.G., Bailey, K.R., Steckelberg, J.M., et al. A systematic review of population-based studies of infective endocarditis. Chest 132 (2007), 1025–1035.
50. Durack, D.T., Lukes, A.S., Bright, D.K., New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994), 200–209.
51. Habib, G., Derumeaux, G., Avierinos, J.F., Casalta, J.P., Jamal, F., Volot, F., et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 33 (1999), 2023–2029.
52. Li, J.S., Sexton, D.J., Mick, N., Nettles, R., Fowler, V.G. Jr., Ryan, T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000), 633–638.
53. Prendergast, B.D., Diagnostic criteria and problems in infective endocarditis. Heart 90 (2004), 611–613.
54. Pettersson, G.B., Hussain, S.T., Shrestha, N.K., Gordon, S., Fraser, T.G., Ibrahim, K.S., et al. Infective endocarditis: an atlas of disease progression for describing, staging, coding, and understanding the pathology. J Thorac Cardiovasc Surg 147 (2014), 1142–1149.e2.
55. Lopez, J., Sevilla, T., Vilacosta, I., Sarria, C., Revilla, A., Ortiz, C., et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J 34 (2013), 1749–1754.
56. Elgharably, H., Hussain, S.T., Shrestha, N.K., Blackstone, E.H., Pettersson, G.B., Current hypotheses in cardiac surgery: biofilm in infective endocarditis. Semin Thorac Cardiovasc Surg 28 (2016), 56–59.
57. Shrestha, N.K., Jue, J., Hussain, S.T., Jerry, J.M., Pettersson, G.B., Menon, V., et al. Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg 100 (2015), 875–882.
58. Houpikian, P., Raoult, D., Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 84 (2005), 162–173.
59. Neugarten, J., Baldwin, D.S., Glomerulonephritis in bacterial endocarditis. Am J Med 77 (1984), 297–304.
60. Hussain, S.T., Blackstone, E.H., Pettersson, G.B., Successful allograft root re-replacement for prosthetic valve endocarditis with improvement of renal function in a Jehovah's Witness patient. J Thorac Cardiovasc Surg 148 (2014), e199–e200.
61. Dickerman, S.A., Abrutyn, E., Barsic, B., Bouza, E., Cecchi, E., Moreno, A., et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 154 (2007), 1086–1094.
62. Hubert, S., Thuny, F., Resseguier, N., Giorgi, R., Tribouilloy, C., Le Dolley, Y., et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol 62 (2013), 1384–1392.
63. Thuny, F., Di Salvo, G., Belliard, O., Avierinos, J.F., Pergola, V., Rosenberg, V., et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 112 (2005), 69–75.
64. Di Salvo, G., Habib, G., Pergola, V., Avierinos, J.F., Philip, E., Casalta, J.P., et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 37 (2001), 1069–1076.
65. Leitman, M., Dreznik, Y., Tyomkin, V., Fuchs, T., Krakover, R., Vered, Z., Vegetation size in patients with infective endocarditis. Eur Heart J Cardiovasc Imaging 13 (2012), 330–338.
66. Hess, A., Klein, I., Iung, B., Lavallee, P., Ilic-Habensus, E., Dornic, Q., et al. Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol 34 (2013), 1579–1584.
67. Cooper, H.A., Thompson, E.C., Laureno, R., Fuisz, A., Mark, A.S., Lin, M., et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 120 (2009), 585–591.
68. Duval, X., Iung, B., Klein, I., Brochet, E., Thabut, G., Arnoult, F., et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 152 (2010), 497–504 W175.
69. Barsic, B., Dickerman, S., Krajinovic, V., Pappas, P., Altclas, J., Carosi, G., et al. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis 56 (2013), 209–217.
70. Patel, F.M., Das, A., Banerjee, A.K., Neuropathological complications of infective endocarditis: study of autopsy material. Neurol India 49 (2001), 41–46.
71. Leport, C., Bure, A., Leport, J., Vilde, J.L., Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet, 1, 1987, 748.
72. Reynolds, J.G., Silva, E., McCormack, W.M., Association of Streptococcus bovis bacteremia with bowel disease. J Clin Microbiol 17 (1983), 696–697.
73. Murray, H.W., Roberts, R.B., Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 138 (1978), 1097–1099.
74. Desch, S., Freund, A., de Waha, S., Eitel, I., Lurz, P., Stiermaier, T., et al. Outcome in patients with left-sided native-valve infective endocarditis and isolated large vegetations. Clin Cardiol 37 (2014), 626–633.
75. Orvin, K., Goldberg, E., Bernstine, H., Groshar, D., Sagie, A., Kornowski, R., et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect 21 (2015), 69–76.
76. Pigrau, C., Almirante, B., Flores, X., Falco, V., Rodriguez, D., Gasser, I., et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med, 118, 2005, 1287.
77. Mekontso Dessap, A., Zahar, J.R., Voiriot, G., Ali, F., Aissa, N., Kirsch, M., et al. Influence of preoperative antibiotherapy on valve culture results and outcome of endocarditis requiring surgery. J Infect 59 (2009), 42–48.
78. De Feo, M., Cotrufo, M., Carozza, A., De Santo, L.S., Amendolara, F., Giordano, S., et al. The need for a specific risk prediction system in native valve infective endocarditis surgery. ScientificWorldJournal, 2012, 2012, 307571.
79. Wang, T.K., Oh, T., Voss, J., Gamble, G., Kang, N., Pemberton, J., Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis. Heart Vessels 30 (2015), 227–234.
80. Cheitlin, M.D., Armstrong, W.F., Aurigemma, G.P., Beller, G.A., Bierman, F.Z., Davis, J.L., et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 16 (2003), 1091–1110.
81. Jassar, A.S., Bavaria, J.E., Szeto, W.Y., Moeller, P.J., Maniaci, J., Milewski, R.K., et al. Graft selection for aortic root replacement in complex active endocarditis: does it matter?. Ann Thorac Surg 93 (2012), 480–487.
82. Kim, J.B., Ejiofor, J.I., Yammine, M., Camuso, J.M., Walsh, C.W., Ando, M., et al. Are homografts superior to conventional prosthetic valves in the setting of infective endocarditis involving the aortic valve?. J Thorac Cardiovasc Surg 151 (2016), 1239–1248.
83. Savage, E.B., Saha-Chaudhuri, P., Asher, C.R., Brennan, J.M., Gammie, J.S., Outcomes and prosthesis choice for active aortic valve infective endocarditis: analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 98 (2014), 806–814.
84. Kirklin, J.K., Challenging homografts as the holy grail for aortic valve endocarditis. J Thorac Cardiovasc Surg 151 (2016), 1230–1231.
85. Sabik, J.F., Lytle, B.W., Blackstone, E.H., Marullo, A.G., Pettersson, G.B., Cosgrove, D.M., Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 74 (2002), 650–659 discussion 9.
86. Von Reyn, C.F., Levy, B.S., Arbeit, R.D., Friedland, G., Crumpacker, C.S., Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 94 (1981), 505–518.
87. Ruiz-Morales, J., Ivanova-Georgieva, R., Fernandez-Hidalgo, N., Garcia-Cabrera, E., Miro, J.M., Munoz, P., et al. Left-sided infective endocarditis in patients with liver cirrhosis. J Infect 71 (2015), 627–641.
88. National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (CG64). National Institute for Health and Care Excellence; 2008. Available at: http://www.nice.org.uk/guidance/CG64.
89. Botelho-Nevers, E., Thuny, F., Casalta, J.P., Richet, H., Gouriet, F., Collart, F., et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 169 (2009), 1290–1298.
90. Habib, G., Badano, L., Tribouilloy, C., Vilacosta, I., Zamorano, J.L., Galderisi, M., et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr 11 (2010), 202–219.
91. Mugge, A., Daniel, W.G., Frank, G., Lichtlen, P.R., Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 14 (1989), 631–638.
92. Reynolds, H.R., Jagen, M.A., Tunick, P.A., Kronzon, I., Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr 16 (2003), 67–70.
93. Ronderos, R.E., Portis, M., Stoermann, W., Sarmiento, C., Are all echocardiographic findings equally predictive for diagnosis in prosthetic endocarditis?. J Am Soc Echocardiogr 17 (2004), 664–669.
94. Tanis, W., Teske, A.J., van Herwerden, L.A., Chamuleau, S., Meijboom, F., Budde, R.P., et al. The additional value of three-dimensional transesophageal echocardiography in complex aortic prosthetic heart valve endocarditis. Echocardiography 32 (2015), 114–125.
95. Bruun, N.E., Habib, G., Thuny, F., Sogaard, P., Cardiac imaging in infectious endocarditis. Eur Heart J 35 (2014), 624–632.
96. San Roman, J.A., Vilacosta, I., Lopez, J., Revilla, A., Arnold, R., Sevilla, T., et al. Role of transthoracic and transesophageal echocardiography in right-sided endocarditis: one echocardiographic modality does not fit all. J Am Soc Echocardiogr 25 (2012), 807–814.
97. Shapira, Y., Weisenberg, D.E., Vaturi, M., Sharoni, E., Raanani, E., Sahar, G., et al. The impact of intraoperative transesophageal echocardiography in infective endocarditis. Isr Med Assoc J 9 (2007), 299–302.
98. Knudsen, J.B., Fuursted, K., Petersen, E., Wierup, P., Molgaard, H., Poulsen, S.H., et al. Failure of clinical features of low probability endocarditis. The early echo remains essential. Scand Cardiovasc J 45 (2011), 133–138.
99. Feuchtner, G.M., Stolzmann, P., Dichtl, W., Schertler, T., Bonatti, J., Scheffel, H., et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol 53 (2009), 436–444.
100. Fagman, E., Perrotta, S., Bech-Hanssen, O., Flinck, A., Lamm, C., Olaison, L., et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol 22 (2012), 2407–2414.
101. Saby, L., Laas, O., Habib, G., Cammilleri, S., Mancini, J., Tessonnier, L., et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 61 (2013), 2374–2382.
102. Pizzi, M.N., Roque, A., Fernandez-Hidalgo, N., Cuellar-Calabria, H., Ferreira-Gonzalez, I., Gonzalez-Alujas, M.T., et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices With 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 132 (2015), 1113–1126.
103. Lancellotti, P., Habib, G., Oury, C., Nchimi, A., Positron emission tomography/computed tomography imaging in device infective endocarditis: ready for prime time. Circulation 132 (2015), 1076–1080.
104. Jault, F., Gandjbakhch, I., Rama, A., Nectoux, M., Bors, V., Vaissier, E., et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 63 (1997), 1737–1741.
105. Nagpal, A., Sohail, M., Steckelberg, J.M., Prosthetic valve endocarditis: state of the heart. Clin Invest 2 (2012), 803–817.
106. Wang, A., Athan, E., Pappas, P.A., Fowler, V.G. Jr., Olaison, L., Pare, C., et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297 (2007), 1354–1361.
107. Hasbun, R., Vikram, H.R., Barakat, L.A., Buenconsejo, J., Quagliarello, V.J., Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 289 (2003), 1933–1940.
108. Funakoshi, S., Kaji, S., Yamamuro, A., Tani, T., Kinoshita, M., Okada, Y., et al. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg 142 (2011), 836–842.e1.
109. Musci, M., Siniawski, H., Pasic, M., Weng, Y., Loforte, A., Kosky, S., et al. Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis. Eur J Cardiothorac Surg 34 (2008), 410–417.
110. Prendergast, B.D., Tornos, P., Surgery for infective endocarditis: who and when?. Circulation 121 (2010), 1141–1152.
111. Bedeir, K., Reardon, M., Ramlawi, B., Infective endocarditis: perioperative management and surgical principles. J Thorac Cardiovasc Surg 147 (2014), 1133–1141.
112. Olaison, L., Pettersson, G., Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 16 (2002), 453–475 xi.
113. Kiefer, T., Park, L., Tribouilloy, C., Cortes, C., Casillo, R., Chu, V., et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306 (2011), 2239–2247.
114. Yu, V.L., Fang, G.D., Keys, T.F., Harris, A.A., Gentry, L.O., Fuchs, P.C., et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 58 (1994), 1073–1077.
115. Miro, J.M., Anguera, I., Cabell, C.H., Chen, A.Y., Stafford, J.A., Corey, G.R., et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41 (2005), 507–514.
116. Remadi, J.P., Habib, G., Nadji, G., Brahim, A., Thuny, F., Casalta, J.P., et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg 83 (2007), 1295–1302.
117. Sohail, M.R., Martin, K.R., Wilson, W.R., Baddour, L.M., Harmsen, W.S., Steckelberg, J.M., Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med 119 (2006), 147–154.
118. Chirouze, C., Cabell, C.H., Fowler, V.G. Jr., Khayat, N., Olaison, L., Miro, J.M., et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis 38 (2004), 1323–1327.
119. Attaran, S., Chukwuemeka, A., Punjabi, P.P., Anderson, J., Do all patients with prosthetic valve endocarditis need surgery?. Interact Cardiovasc Thorac Surg 15 (2012), 1057–1061.
120. Wolff, M., Witchitz, S., Chastang, C., Regnier, B., Vachon, F., Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest 108 (1995), 688–694.
121. Melgar, G.R., Nasser, R.M., Gordon, S.M., Lytle, B.W., Keys, T.F., Longworth, D.L., Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine (Baltimore) 76 (1997), 94–103.
122. Habib, G., Avierinos, J.F., Thuny, F., Aortic valve endocarditis: is there an optimal surgical timing?. Curr Opin Cardiol 22 (2007), 77–83.
123. Spiliopoulos, K., Haschemi, A., Fink, G., Kemkes, B.M., Infective endocarditis complicated by paravalvular abscess: a surgical challenge. An 11-year single center experience. Heart Surg Forum 13 (2010), E67–E73.
124. David, T.E., Regesta, T., Gavra, G., Armstrong, S., Maganti, M.D., Surgical treatment of paravalvular abscess: long-term results. Eur J Cardiothorac Surg 31 (2007), 43–48.
125. Thuny, F., Beurtheret, S., Mancini, J., Gariboldi, V., Casalta, J.P., Riberi, A., et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 32 (2011), 2027–2033.
126. Yankah, A.C., Pasic, M., Klose, H., Siniawski, H., Weng, Y., Hetzer, R., Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg 28 (2005), 69–75.
127. Lytle, B.W., Sabik, J.F., Blackstone, E.H., Svensson, L.G., Pettersson, G.B., Cosgrove, D.M. 3rd, Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg 74 (2002), S1754–S1757 discussion S92-9.
128. d'Udekem, Y., David, T.E., Feindel, C.M., Armstrong, S., Sun, Z., Long-term results of operation for paravalvular abscess. Ann Thorac Surg 62 (1996), 48–53.
129. Alonso-Valle, H., Farinas-Alvarez, C., Garcia-Palomo, J.D., Bernal, J.M., Martin-Duran, R., Gutierrez Diez, J.F., et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg 139 (2010), 887–893.
130. Hill, E.E., Herijgers, P., Claus, P., Vanderschueren, S., Peetermans, W.E., Herregods, M.C., Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J 154 (2007), 923–928.
131. Rohmann, S., Erbel, R., Darius, H., Gorge, G., Makowski, T., Zotz, R., et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 4 (1991), 465–474.
132. Habib, G., Embolic risk in subacute bacterial endocarditis: determinants and role of transesophageal echocardiography. Curr Infect Dis Rep 7 (2005), 264–271.
133. Vilacosta, I., Graupner, C., San Roman, J.A., Sarria, C., Ronderos, R., Fernandez, C., et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 39 (2002), 1489–1495.
134. Okonta, K.E., Adamu, Y.B., What size of vegetation is an indication for surgery in endocarditis?. Interact Cardiovasc Thorac Surg 15 (2012), 1052–1056.
135. Sanfilippo, A.J., Picard, M.H., Newell, J.B., Rosas, E., Davidoff, R., Thomas, J.D., et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 18 (1991), 1191–1199.
136. Musci, M., Siniawski, H., Pasic, M., Grauhan, O., Weng, Y., Meyer, R., et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg 32 (2007), 118–125.
137. Thuny, F., Avierinos, J.F., Tribouilloy, C., Giorgi, R., Casalta, J.P., Milandre, L., et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 28 (2007), 1155–1161.
138. Garcia-Cabrera, E., Fernandez-Hidalgo, N., Almirante, B., Ivanova-Georgieva, R., Noureddine, M., Plata, A., et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 127 (2013), 2272–2284.
139. Thuny, F., Habib, G., When should we operate on patients with acute infective endocarditis?. Heart 96 (2010), 892–897.
140. Angstwurm, K., Borges, A.C., Halle, E., Schielke, E., Einhaupl, K.M., Weber, J.R., Timing the valve replacement in infective endocarditis involving the brain. J Neurol 251 (2004), 1220–1226.
141. Eishi, K., Kawazoe, K., Kuriyama, Y., Kitoh, Y., Kawashima, Y., Omae, T., Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 110 (1995), 1745–1755.
142. Gillinov, A.M., Shah, R.V., Curtis, W.E., Stuart, R.S., Cameron, D.E., Baumgartner, W.A., et al. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 61 (1996), 1125–1129 discussion 30.
143. Ting, W., Silverman, N., Levitsky, S., Valve replacement in patients with endocarditis and cerebral septic emboli. Ann Thorac Surg 51 (1991), 18–21 discussion 2.
144. Kanter, M.C., Hart, R.G., Neurologic complications of infective endocarditis. Neurology 41 (1991), 1015–1020.
145. Piper, C., Wiemer, M., Schulte, H.D., Horstkotte, D., Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 10 (2001), 703–711.
146. Ruttmann, E., Willeit, J., Ulmer, H., Chevtchik, O., Hofer, D., Poewe, W., et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 37 (2006), 2094–2099.
147. Chu, V.H., Park, L.P., Athan, E., Delahaye, F., Freiberger, T., Lamas, C., et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation 131 (2015), 131–140.
148. Ohara, T., Nakatani, S., Kokubo, Y., Yamamoto, H., Mitsutake, K., Hanai, S., et al. Clinical predictors of in-hospital death and early surgery for infective endocarditis: results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. Int J Cardiol 167 (2013), 2688–2694.
149. Gelsomino, S., Maessen, J.G., van der Veen, F., Livi, U., Renzulli, A., Luca, F., et al. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thorac Surg 93 (2012), 1469–1476.
150. Sonneville, R., Mirabel, M., Hajage, D., Tubach, F., Vignon, P., Perez, P., et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 39 (2011), 1474–1481.
151. Bannay, A., Hoen, B., Duval, X., Obadia, J.F., Selton-Suty, C., Le Moing, V., et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?. Eur Heart J 32 (2011), 2003–2015.
152. Shang, E., Forrest, G.N., Chizmar, T., Chim, J., Brown, J.M., Zhan, M., et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg 87 (2009), 1728–1733 discussion 34.
153. Heiro, M., Nikoskelainen, J., Engblom, E., Kotilainen, E., Marttila, R., Kotilainen, P., Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 160 (2000), 2781–2787.
154. Anderson, D.J., Goldstein, L.B., Wilkinson, W.E., Corey, G.R., Cabell, C.H., Sanders, L.L., et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology 61 (2003), 1341–1346.
155. Hui, F.K., Bain, M., Obuchowski, N.A., Gordon, S., Spiotta, A.M., Moskowitz, S., et al. Mycotic aneurysm detection rates with cerebral angiography in patients with infective endocarditis. J Neurointerv Surg 7 (2015), 449–452.
156. Sorabella, R.A., Han, S.M., Grbic, M., Wu, Y.S., Takyama, H., Kurlansky, P., et al. Early operation for endocarditis complicated by preoperative cerebral emboli is not associated with worsened outcomes. Ann Thorac Surg 100 (2015), 501–508.
157. Okita, Y., Minakata, K., Yasuno, S., Uozumi, R., Sato, T., Ueshima, K., et al. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre studydagger. Eur J Cardiothorac Surg 50 (2016), 374–382.
158. Yoshioka, D., Toda, K., Sakaguchi, T., Okazaki, S., Yamauchi, T., Miyagawa, S., et al. Valve surgery in active endocarditis patients complicated by intracranial haemorrhage: the influence of the timing of surgery on neurological outcomes. Eur J Cardiothorac Surg 45 (2014), 1082–1088.
159. Masuda, J., Yutani, C., Waki, R., Ogata, J., Kuriyama, Y., Yamaguchi, T., Histopathological analysis of the mechanisms of intracranial hemorrhage complicating infective endocarditis. Stroke 23 (1992), 843–850.
160. Morita, K., Sasabuchi, Y., Matsui, H., Fushimi, K., Yasunaga, H., Outcomes after early or late timing of surgery for infective endocarditis with ischaemic stroke: a retrospective cohort study. Interact Cardiovasc Thorac Surg 21 (2015), 604–609.
161. Yoshioka, D., Sakaguchi, T., Yamauchi, T., Okazaki, S., Miyagawa, S., Nishi, H., et al. Impact of early surgical treatment on postoperative neurologic outcome for active infective endocarditis complicated by cerebral infarction. Ann Thorac Surg 94 (2012), 489–495 discussion 96.
162. Misfeld, M., Girrbach, F., Etz, C.D., Binner, C., Aspern, K.V., Dohmen, P.M., et al. Surgery for infective endocarditis complicated by cerebral embolism: a consecutive series of 375 patients. J Thorac Cardiovasc Surg 147 (2014), 1837–1844.
163. Kamalakannan, D., Muhammed, B., Gardin, J., Anticoagulation in infective endocarditis. A survey of infectious disease specialists and cardiologists. Infect Dis Clin Pract 13 (2005), 122–126.
164. Goldstein, J.N., Greenberg, S.M., Should anticoagulation be resumed after intracerebral hemorrhage?. Cleve Clin J Med 77 (2010), 791–799.
165. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. Stroke 15 (1984), 779–789.
166. Tunkel, A.R., Kaye, D., Neurologic complications of infective endocarditis. Neurol Clin 11 (1993), 419–440.
167. Ananthasubramaniam, K., Beattie, J.N., Rosman, H.S., Jayam, V., Borzak, S., How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?. Chest 119 (2001), 478–484.
168. Wilson, W.R., Geraci, J.E., Danielson, G.K., Thompson, R.L., Spittell, J.A. Jr., Washington, J.R. 2nd, et al. Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis. Circulation 57 (1978), 1004–1007.
169. Lieberman, A., Hass, W.K., Pinto, R., Isom, W.O., Kupersmith, M., Bear, G., et al. Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves. Stroke 9 (1978), 18–24.
170. Carpenter, J.L., McAllister, C.K., Anticoagulation in prosthetic valve endocarditis. South Med J 76 (1983), 1372–1375.
171. Tornos, P., Almirante, B., Mirabet, S., Permanyer, G., Pahissa, A., Soler-Soler, J., Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 159 (1999), 473–475.
172. Snygg-Martin, U., Gustafsson, L., Rosengren, L., Alsio, A., Ackerholm, P., Andersson, R., et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47 (2008), 23–30.
173. Rasmussen, R.V., Snygg-Martin, U., Olaison, L., Buchholtz, K., Larsen, C.T., Hassager, C., et al. Major cerebral events in Staphylococcus aureus infective endocarditis: is anticoagulant therapy safe?. Cardiology 114 (2009), 284–291.
174. Anavekar, N.S., Tleyjeh, I.M., Mirzoyev, Z., Steckelberg, J.M., Haddad, C., Khandaker, M.H., et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 44 (2007), 1180–1186.
175. Chan, K.L., Dumesnil, J.G., Cujec, B., Sanfilippo, A.J., Jue, J., Turek, M.A., et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 42 (2003), 775–780.
176. Chan, K.L., Tam, J., Dumesnil, J.G., Cujec, B., Sanfilippo, A.J., Jue, J., et al. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 46 (2008), 37–41.
177. Kung, V.W., Jarral, O.A., Shipolini, A.R., McCormack, D.J., Is it safe to perform coronary angiography during acute endocarditis?. Interact Cardiovasc Thorac Surg 13 (2011), 158–167.
178. Roselli, E.E., Pettersson, G.B., Blackstone, E.H., Brizzio, M.E., Houghtaling, P.L., Hauck, R., et al. Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J Thorac Cardiovasc Surg 135 (2008), 316–323 e1-6.
179. Voldstedlund, M., Fuursted, K., Bruun, N.E., Arpi, M., Comparison of heart valve culture between two Danish endocarditis centres. Scand J Infect Dis 44 (2012), 405–413.
180. Olaison, L., Hogevik, H., Myken, P., Oden, A., Alestig, K., Early surgery in infective endocarditis. QJM 89 (1996), 267–278.
181. Fayad, G., Vincentelli, A., Leroy, G., Devos, P., Amr, G., Prat, A., et al. Impact of antimicrobial therapy on prognosis of patients requiring valve surgery during active infective endocarditis. J Thorac Cardiovasc Surg 147 (2014), 254–258.
182. Pettersson, G.B., Martino, D., Blackstone, E.H., Nowicki, E.R., Houghtaling, P.L., Sabik, J.F. 3rd, et al. Advising complex patients who require complex heart operations. J Thorac Cardiovasc Surg 145 (2013), 1159–1169.e3.
183. Oxorn, D.C., Intraoperative echocardiography. Heart 94 (2008), 1236–1243.
184. Yao, F., Han, L., Xu, Z.Y., Zou, L.J., Huang, S.D., Wang, Z.N., et al. Surgical treatment of multivalvular endocarditis: twenty-one-year single center experience. J Thorac Cardiovasc Surg 137 (2009), 1475–1480.
185. Grimm, R.A., Stewart, W.J., The role of intraoperative echocardiography in valve surgery. Cardiol Clin 16 (1998), 477–489 ix.
186. Eltzschig, H.K., Rosenberger, P., Loffler, M., Fox, J.A., Aranki, S.F., Shernan, S.K., Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg 85 (2008), 845–852.
187. Silva, F., Arruda, R., Nobre, A., Mendes, M., Lemos, A., Gallego, J., et al. Impact of intraoperative transesophageal echocardiography in cardiac surgery: retrospective analysis of a series of 850 examinations. Rev Port Cardiol 29 (2010), 1363–1382.
188. de Kerchove, L., Vanoverschelde, J.L., Poncelet, A., Glineur, D., Rubay, J., Zech, F., et al. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardiothorac Surg 31 (2007), 592–599.
189. Shimokawa, T., Kasegawa, H., Matsuyama, S., Seki, H., Manabe, S., Fukui, T., et al. Long-term outcome of mitral valve repair for infective endocarditis. Ann Thorac Surg 88 (2009), 733–739 discussion 9.
190. Doukas, G., Oc, M., Alexiou, C., Sosnowski, A.W., Samani, N.J., Spyt, T.J., Mitral valve repair for active culture positive infective endocarditis. Heart 92 (2006), 361–363.
191. Feringa, H.H., Shaw, L.J., Poldermans, D., Hoeks, S., van der Wall, E.E., Dion, R.A., et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg 83 (2007), 564–570.
192. Ruttmann, E., Legit, C., Poelzl, G., Mueller, S., Chevtchik, O., Cottogni, M., et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg 130 (2005), 765–771.
193. Zegdi, R., Debieche, M., Latremouille, C., Lebied, D., Chardigny, C., Grinda, J.M., et al. Long-term results of mitral valve repair in active endocarditis. Circulation 111 (2005), 2532–2536.
194. Feringa, H.H., Bax, J.J., Klein, P., Klautz, R.J., Braun, J., van der Wall, E.E., et al. Outcome after mitral valve repair for acute and healed infective endocarditis. Eur J Cardiothorac Surg 29 (2006), 367–373.
195. Iung, B., Rousseau-Paziaud, J., Cormier, B., Garbarz, E., Fondard, O., Brochet, E., et al. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol 43 (2004), 386–392.
196. Muehrcke, D.D., Cosgrove, D.M. 3rd, Lytle, B.W., Taylor, P.C., Burgar, A.M., Durnwald, C.P., et al. Is there an advantage to repairing infected mitral valves?. Ann Thorac Surg 63 (1997), 1718–1724.
197. David, T.E., Aortic valve repair for active infective endocarditis. Eur J Cardiothorac Surg 42 (2012), 127–128.
198. Mayer, K., Aicher, D., Feldner, S., Kunihara, T., Schafers, H.J., Repair versus replacement of the aortic valve in active infective endocarditis. Eur J Cardiothorac Surg 42 (2012), 122–127.
199. Moon, M.R., Miller, D.C., Moore, K.A., Oyer, P.E., Mitchell, R.S., Robbins, R.C., et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 71 (2001), 1164–1171.
200. Haydock, D., Barratt-Boyes, B., Macedo, T., Kirklin, J.W., Blackstone, E., Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 103 (1992), 130–139.
201. Kaiser, S.P., Melby, S.J., Zierer, A., Schuessler, R.B., Moon, M.R., Moazami, N., et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg 83 (2007), 30–35.
202. Lytle, B.W., Priest, B.P., Taylor, P.C., Loop, F.D., Sapp, S.K., Stewart, R.W., et al. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg 111 (1996), 198–207 discussion 10.
203. Sheikh, A.M., Elhenawy, A.M., Maganti, M., Armstrong, S., David, T.E., Feindel, C.M., Outcomes of surgical intervention for isolated active mitral valve endocarditis. J Thorac Cardiovasc Surg 137 (2009), 110–116.
204. Grinda, J.M., Mainardi, J.L., D'Attellis, N., Bricourt, M.O., Berrebi, A., Fabiani, J.N., et al. Cryopreserved aortic viable homograft for active aortic endocarditis. Ann Thorac Surg 79 (2005), 767–771.
205. El-Hamamsy, I., Clark, L., Stevens, L.M., Sarang, Z., Melina, G., Takkenberg, J.J., et al. Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol 55 (2010), 368–376.
206. Musci, M., Weng, Y., Hubler, M., Amiri, A., Pasic, M., Kosky, S., et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience. J Thorac Cardiovasc Surg 139 (2010), 665–673.
207. Siniawski, H., Lehmkuhl, H., Weng, Y., Pasic, M., Yankah, C., Hoffmann, M., et al. Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg 75 (2003), 803–808 discussion 8.
208. Perrotta, S., Lentini, S., In patients with severe active aortic valve endocarditis, is a stentless valve as good as the homograft?. Interact Cardiovasc Thorac Surg 11 (2010), 309–313.
209. McGiffin, D.C., Galbraith, A.J., McLachlan, G.J., Stower, R.E., Wong, M.L., Stafford, E.G., et al. Aortic valve infection. Risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 104 (1992), 511–520.
210. Avierinos, J.F., Thuny, F., Chalvignac, V., Giorgi, R., Tafanelli, L., Casalta, J.P., et al. Surgical treatment of active aortic endocarditis: homografts are not the cornerstone of outcome. Ann Thorac Surg 84 (2007), 1935–1942.
211. Mihaljevic, T., Invited commentary. It would not be wise to completely abandon the use of homograft root replacement in particular in patients with prosthetic valve endocarditis and aortic root abscess. Ann Thorac Surg, 84, 2007, 1942.
212. Leyh, R.G., Knobloch, K., Hagl, C., Ruhparwar, A., Fischer, S., Kofidis, T., et al. Replacement of the aortic root for acute prosthetic valve endocarditis: prosthetic composite versus aortic allograft root replacement. J Thorac Cardiovasc Surg 127 (2004), 1416–1420.
213. Dearani, J.A., Orszulak, T.A., Schaff, H.V., Daly, R.C., Anderson, B.J., Danielson, G.K., Results of allograft aortic valve replacement for complex endocarditis. J Thorac Cardiovasc Surg 113 (1997), 285–291.
214. Moon, M.R., Prosthetic valve selection in patients with left-sided endocarditis: bioprosthetic or mechanical valves?. Curr Opin Cardiol 29 (2014), 127–132.
215. Gross, C., Klima, U., Mair, R., Brucke, P., Aortic homografts versus mechanical valves in aortic valve replacement in young patients: a retrospective study. Ann Thorac Surg 66 (1998), S194–S197.
216. Gulbins, H., Kilian, E., Roth, S., Uhlig, A., Kreuzer, E., Reichart, B., Is there an advantage in using homografts in patients with acute infective endocarditis of the aortic valve?. J Heart Valve Dis 11 (2002), 492–497.
217. Klieverik, L.M., Yacoub, M.H., Edwards, S., Bekkers, J.A., Roos-Hesselink, J.W., Kappetein, A.P., et al. Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg 88 (2009), 1814–1821.
218. Evans, C.F., Gammie, J.S., Surgical management of mitral valve infective endocarditis. Semin Thorac Cardiovasc Surg 23 (2011), 232–240.
219. Sheikh, A.M., Elhenawy, A.M., Maganti, M., Armstrong, S., David, T.E., Feindel, C.M., Outcomes of double valve surgery for active infective endocarditis. J Thorac Cardiovasc Surg 138 (2009), 69–75.
220. Gillinov, A.M., Diaz, R., Blackstone, E.H., Pettersson, G.B., Sabik, J.F., Lytle, B.W., et al. Double valve endocarditis. Ann Thorac Surg 71 (2001), 1874–1879.
221. David, T.E., Surgical management of aortic root abscess. J Card Surg 12 (1997), 262–266 discussion 6-9.
222. Siniawski, H., Grauhan, O., Hofmann, M., Pasic, M., Weng, Y., Yankah, C., et al. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment. Eur J Cardiothorac Surg 27 (2005), 434–440.
223. Pettersson, G.B., Hussain, S.T., Ramankutty, R.M., Lytle, B.W., Blackstone, E.H., Reconstruction of fibrous skeleton: technique, pitfalls and results. Multimed Man Cardiothorac Surg, 2014, 2014.
224. Leontyev, S., Borger, M.A., Modi, P., Lehmann, S., Seeburger, J., Doenst, T., et al. Surgical management of aortic root abscess: a 13-year experience in 172 patients with 100% follow-up. J Thorac Cardiovasc Surg 143 (2012), 332–337.
225. De Oliveira, N.C., David, T.E., Armstrong, S., Ivanov, J., Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: an analysis of clinical outcomes. J Thorac Cardiovasc Surg 129 (2005), 286–290.
226. David, T.E., Kuo, J., Armstrong, S., Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body. J Thorac Cardiovasc Surg 114 (1997), 766–771 discussion 71-2.
227. Davierwala, P.M., Binner, C., Subramanian, S., Luehr, M., Pfannmueller, B., Etz, C., et al. Double valve replacement and reconstruction of the intervalvular fibrous body in patients with active infective endocarditis. Eur J Cardiothorac Surg 45 (2014), 146–152.
228. Kim, S.W., Park, P.W., Kim, W.S., Sung, K., Lee, Y.T., Jun, T.G., et al. Long-term results of aortomitral fibrous body reconstruction with double-valve replacement. Ann Thorac Surg 95 (2013), 635–641.
229. Navia, J.L., Al-Ruzzeh, S., Gordon, S., Fraser, T., Aguero, O., Rodriguez, L., The incorporated aortomitral homograft: a new surgical option for double valve endocarditis. J Thorac Cardiovasc Surg 139 (2010), 1077–1081.
230. Akinosoglou, K., Apostolakis, E., Koutsogiannis, N., Leivaditis, V., Gogos, C.A., Right-sided infective endocarditis: surgical management. Eur J Cardiothorac Surg 42 (2012), 470–479.
231. Gaca, J.G., Sheng, S., Daneshmand, M., Rankin, J.S., Williams, M.L., O'Brien, S.M., et al. Current outcomes for tricuspid valve infective endocarditis surgery in North America. Ann Thorac Surg 96 (2013), 1374–1381.
232. Jiang, S.L., Li, B.J., Zhang, T., Ren, C.L., Wang, Y., Chen, T.T., et al. Surgical treatment of isolated right-sided infective endocarditis. Tex Heart Inst J 38 (2011), 639–642.
233. Dawood, M.Y., Cheema, F.H., Ghoreishi, M., Foster, N.W., Villanueva, R.M., Salenger, R., et al. Contemporary outcomes of operations for tricuspid valve infective endocarditis. Ann Thorac Surg 99 (2015), 539–546.
234. Miro, J.M., del Rio, A., Mestres, C.A., Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 21 (2003), 167–184 v-vi.
235. Baraki, H., Saito, S., Al Ahmad, A., Fleischer, B., Schmitto, J., Haverich, A., et al. Surgical treatment for isolated tricuspid valve endocarditis- long-term follow-up at a single institution. Circ J 77 (2013), 2032–2037.
236. Carozza, A., De Santo, L.S., Romano, G., Della Corte, A., Ursomando, F., Scardone, M., et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis 15 (2006), 125–131.
237. Frontera, J.A., Gradon, J.D., Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 30 (2000), 374–379.
238. Thalme, A., Westling, K., Julander, I., In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes. Scand J Infect Dis 39 (2007), 197–204.
239. Yamane, K., Hirose, H., Bogar, L.J., Cavarocchi, N.C., Diehl, J.T., Surgical treatment of infective endocarditis in patients undergoing chronic hemodialysis. J Heart Valve Dis 21 (2012), 774–782.
240. Arbulu, A., Holmes, R.J., Asfaw, I., Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. J Heart Valve Dis 2 (1993), 129–137 discussion 38-9.
241. Kamaledeen, A., Young, C., Attia, R.Q., What are the differences in outcomes between right-sided active infective endocarditis with and without left-sided infection?. Interact Cardiovasc Thorac Surg 14 (2012), 205–208.
242. Rabkin, D.G., Mokadam, N.A., Miller, D.W., Goetz, R.R., Verrier, E.D., Aldea, G.S., Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg 93 (2012), 51–57.
243. Tarola, C.L., Losenno, K.L., Chu, M.W., Complex tricuspid valve repair for infective endocarditis: leaflet augmentation, chordae and annular reconstruction. Multimed Man Cardiothorac Surg, 2015, 2015.
244. Gottardi, R., Bialy, J., Devyatko, E., Tschernich, H., Czerny, M., Wolner, E., et al. Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg 84 (2007), 1943–1948.
245. Hagl, C., Galla, J.D., Lansman, S.L., Fink, D., Bodian, C.A., Spielvogel, D., et al. Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated?. Ann Thorac Surg 74 (2002), S1781–S1785 discussion S92-9.
246. LeMaire, S.A., Coselli, J.S., Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg 134 (2007), 839–843.
247. Tang, G.H., Pinney, S.P., Broumand, S.R., Adams, D.H., Anyanwu, A.C., Excellent outcomes with use of synthetic vascular grafts for treatment of mycotic aortic pseudoaneurysms after heart transplantation. Ann Thorac Surg 92 (2011), 2112–2116.
248. Shah, D.K., Li, Z., Park, S.J., Daly, R.C., Dearani, J.A., Schaff, H.V., et al. Replacement of the infected composite aortic root prosthesis. Ann Thorac Surg 92 (2011), 1651–1655.
249. Tossios, P., Karatzopoulos, A., Tsagakis, K., Sapalidis, K., Grosomanidis, V., Kalogera, A., et al. Treatment of infected thoracic aortic prosthetic grafts with the in situ preservation strategy: a review of its history, surgical technique, and results. Heart Lung Circ 23 (2014), 24–31.
250. Sohail, M.R., Uslan, D.Z., Khan, A.H., Friedman, P.A., Hayes, D.L., Wilson, W.R., et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 83 (2008), 46–53.
251. Tarakji, K.G., Wilkoff, B.L., Cardiac implantable electronic device infections: facts, current practice, and the unanswered questions. Curr Infect Dis Rep, 16, 2014, 425.
252. Athan, E., Chu, V.H., Tattevin, P., Selton-Suty, C., Jones, P., Naber, C., et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307 (2012), 1727–1735.
253. Viganego, F., O'Donoghue, S., Eldadah, Z., Shah, M.H., Rastogi, M., Mazel, J.A., et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. Am J Cardiol 109 (2012), 1466–1471.
254. Pichlmaier, M., Knigina, L., Kutschka, I., Bara, C., Oswald, H., Klein, G., et al. Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection. J Thorac Cardiovasc Surg 142 (2011), 1482–1490.
255. Rundstrom, H., Kennergren, C., Andersson, R., Alestig, K., Hogevik, H., Pacemaker endocarditis during 18 years in Goteborg. Scand J Infect Dis 36 (2004), 674–679.
256. Baddour, L.M., Epstein, A.E., Erickson, C.C., Knight, B.P., Levison, M.E., Lockhart, P.B., et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121 (2010), 458–477.
257. Baddour, L.M., Cha, Y.M., Wilson, W.R., Clinical practice. Infections of cardiovascular implantable electronic devices. N Engl J Med 367 (2012), 842–849.
258. Madhavan, M., Sohail, M.R., Friedman, P.A., Hayes, D.L., Steckelberg, J.M., Wilson, W.R., et al. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol 3 (2010), 639–645.
259. Shrestha, N.K., Ledtke, C.S., Wang, H., Fraser, T.G., Rehm, S.J., Hussain, S.T., et al. Heart valve culture and sequencing to identify the infective endocarditis pathogen in surgically treated patients. Ann Thorac Surg 99 (2015), 33–37.
260. Fournier, P.E., Thuny, F., Richet, H., Lepidi, H., Casalta, J.P., Arzouni, J.P., et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51 (2010), 131–140.
261. Boussier, R., Rogez, S., Francois, B., Denes, E., Ploy, M.C., Garnier, F., Two-step bacterial broad-range polymerase chain reaction analysis of heart valve tissue improves bacteriological diagnosis of infective endocarditis. Diagn Microbiol Infect Dis 75 (2013), 240–244.
262. Greub, G., Lepidi, H., Rovery, C., Casalta, J.P., Habib, G., Collard, F., et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 118 (2005), 230–238.
263. Marin, M., Munoz, P., Sanchez, M., del Rosal, M., Alcala, L., Rodriguez-Creixems, M., et al. Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86 (2007), 195–202.
264. Vollmer, T., Piper, C., Horstkotte, D., Korfer, R., Kleesiek, K., Dreier, J., 23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis. Eur Heart J 31 (2010), 1105–1113.
265. Dahl, A., Rasmussen, R.V., Bundgaard, H., Hassager, C., Bruun, L.E., Lauridsen, T.K., et al. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation 127 (2013), 1810–1817.
266. Olaison, L., Schadewitz, K., Swedish Society of Infectious Diseases Quality Assurance Study Group for E. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?. Clin Infect Dis 34 (2002), 159–166.
267. Thomsen, R.W., Farkas, D.K., Friis, S., Svaerke, C., Ording, A.G., Norgaard, M., et al. Endocarditis and risk of cancer: a Danish nationwide cohort study. Am J Med 126 (2013), 58–67.
268. Gupta, A., Madani, R., Mukhtar, H., Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis 12 (2010), 164–171.
269. Rusniok, C., Couve, E., Da Cunha, V., El Gana, R., Zidane, N., Bouchier, C., et al. Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol 192 (2010), 2266–2276.
270. Boleij, A., van Gelder, M.M., Swinkels, D.W., Tjalsma, H., Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 53 (2011), 870–878.
271. Thuny, F., Giorgi, R., Habachi, R., Ansaldi, S., Le Dolley, Y., Casalta, J.P., et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 164 (2012), 94–101.
272. Hasegawa, M.I., Kyo, S., Asano, H., Imanaka, K., Surgery for active, culture negative endocarditis. Asian Cardiovasc Thorac Ann 12 (2004), 316–319.
273. Mullany, C.J., Chua, Y.L., Schaff, H.V., Steckelberg, J.M., Ilstrup, D.M., Orszulak, T.A., et al. Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc 70 (1995), 517–525.
274. Fedoruk, L.M., Jamieson, W.R., Ling, H., Macnab, J.S., Germann, E., Karim, S.S., et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg 137 (2009), 326–333.
275. Martinez-Selles, M., Munoz, P., Estevez, A., del Castillo, R., Garcia-Fernandez, M.A., Rodriguez-Creixems, M., et al. Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc 83 (2008), 1213–1217.
276. Mansur, A.J., Dal Bo, C.M., Fukushima, J.T., Issa, V.S., Grinberg, M., Pomerantzeff, P.M., Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J 141 (2001), 78–86.
277. Tornos, M.P., Permanyer-Miralda, G., Olona, M., Gil, M., Galve, E., Almirante, B., et al. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med 117 (1992), 567–572.
278. Westling, K., Aufwerber, E., Ekdahl, C., Friman, G., Gardlund, B., Julander, I., et al. Swedish guidelines for diagnosis and treatment of infective endocarditis. Scand J Infect Dis 39 (2007), 929–946.
279. Nori, U.S., Manoharan, A., Thornby, J.I., Yee, J., Parasuraman, R., Ramanathan, V., Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant 21 (2006), 2184–2190.
280. Rankin, J.S., Milford-Beland, S., O'Brien, S.M., Edwards, F.H., Peterson, E.D., Glower, D.D., et al. The risk of valve surgery for endocarditis in patients with dialysis-dependent renal failure. J Heart Valve Dis 16 (2007), 617–622 discussion 22.
281. Leither, M.D., Shroff, G.R., Ding, S., Gilbertson, D.T., Herzog, C.A., Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation 128 (2013), 344–351.
282. Abbott, K.C., Agodoa, L.Y., Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 91 (2002), 203–209.
283. Doulton, T., Sabharwal, N., Cairns, H.S., Schelenz, S., Eykyn, S., O'Donnell, P., et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int 64 (2003), 720–727.
284. Maraj, S., Jacobs, L.E., Maraj, R., Kotler, M.N., Bacteremia and infective endocarditis in patients on hemodialysis. Am J Med Sci 327 (2004), 242–249.
285. McCarthy, J.T., Steckelberg, J.M., Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 75 (2000), 1008–1014.
286. Hung, T.H., Hsieh, Y.H., Tseng, K.C., Tsai, C.C., The risk for bacterial endocarditis in cirrhotic patients: a population-based 3-year follow-up study. Int J Infect Dis 17 (2013), e391–e393.
287. Jacob, K.A., Hjortnaes, J., Kranenburg, G., de Heer, F., Kluin, J., Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score. Interact Cardiovasc Thorac Surg 20 (2015), 520–530.
288. Wilson, W., Taubert, K.A., Gewitz, M., Lockhart, P.B., Baddour, L.M., Levison, M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007), 1736–1754.